A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.

Service, facilitating affordable access for SMBs. Generative AI leads in market share, while image and video modalities ...

Evidation, the leader in direct-from-participant real-world data and health research, is announcing the launch of a first-of-its-kind temporal biospecimen collection platform to support multiomics ...

Scott Hazlett, Vice President of Business Development at PSI says, "WOCNCB is an industry leader in specialist nursing certification, and we look forward to supporting their programs with cutting-edge ...

Chinese AI startup Zhipu AI announced on Wednesday that it has partnered with Huawei to open-source GLM-Image, a ...

First, multimodal imaging, demographic, and clinical data obtained from 90-d HDTBR experiment. Further statistical analyses were conducted for alteration of CBF. Next, the CBF prediction models were ...

ETRI, South Korea’s leading government-funded research institute, is establishing itself as a key research entity for ...